Published in Graefes Arch Clin Exp Ophthalmol on August 26, 2011
'Structure-function relationship' in glaucoma: past thinking and current concepts. Clin Experiment Ophthalmol (2012) 1.53
[Conventional perimetry. Antiquated or indispensable for functional glaucoma diagnostics?]. Ophthalmologe (2012) 0.83
Bis(zinc-dipicolylamine), Zn-DPA, a new marker for apoptosis. Invest Ophthalmol Vis Sci (2014) 0.76
Pediatric Glaucoma: A Literature's Review and Analysis of Surgical Results. Biomed Res Int (2015) 0.76
Clinical Signs and Diagnosis of the Canine Primary Glaucomas. Vet Clin North Am Small Anim Pract (2015) 0.75
Relationship between consecutive deterioration of mean deviation value and progression of visual field defect in open-angle glaucoma. Clin Ophthalmol (2015) 0.75
Assessment of Structural Glaucoma Progression. J Curr Glaucoma Pract (2012) 0.75
Can Visual Field Progression be Predicted by Confocal Scanning Laser Ophthalmoscopic Imaging of the Optic Nerve Head in Glaucoma? (An American Ophthalmological Society Thesis). Trans Am Ophthalmol Soc (2015) 0.75
Evaluation of the progression of visual field damage in patients suffering from early manifest glaucoma. Clin Ophthalmol (2016) 0.75
Diagnostic performance of isolated-check visual evoked potential versus retinal ganglion cell-inner plexiform layer analysis in early primary open-angle glaucoma. BMC Ophthalmol (2017) 0.75
The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol (2002) 11.38
Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol (2003) 8.76
Retinal ganglion cell atrophy correlated with automated perimetry in human eyes with glaucoma. Am J Ophthalmol (1989) 6.53
Number of ganglion cells in glaucoma eyes compared with threshold visual field tests in the same persons. Invest Ophthalmol Vis Sci (2000) 4.19
A visual field index for calculation of glaucoma rate of progression. Am J Ophthalmol (2008) 3.46
Practical recommendations for measuring rates of visual field change in glaucoma. Br J Ophthalmol (2008) 3.25
Ganglion cell losses underlying visual field defects from experimental glaucoma. Invest Ophthalmol Vis Sci (1999) 3.25
Normal variability of static perimetric threshold values across the central visual field. Arch Ophthalmol (1987) 3.22
Advanced Glaucoma Intervention Study. 2. Visual field test scoring and reliability. Ophthalmology (1994) 3.20
Natural history of open-angle glaucoma. Ophthalmology (2009) 2.99
Early detection of visual field progression in glaucoma: a comparison of PROGRESSOR and STATPAC 2. Br J Ophthalmol (1997) 2.88
Risk factors for progression of visual field abnormalities in normal-tension glaucoma. Am J Ophthalmol (2001) 2.84
A method to measure and predict rates of regional visual field decay in glaucoma. Invest Ophthalmol Vis Sci (2011) 2.78
Early Manifest Glaucoma Trial: design and baseline data. Ophthalmology (1999) 2.74
Intercurrent factors associated with the development of open-angle glaucoma in the European glaucoma prevention study. Am J Ophthalmol (2007) 2.73
Test-retest variability in glaucomatous visual fields. Am J Ophthalmol (1989) 2.40
Scaling the hill of vision: the physiological relationship between light sensitivity and ganglion cell numbers. Invest Ophthalmol Vis Sci (2000) 2.33
Glaucoma Hemifield Test. Automated visual field evaluation. Arch Ophthalmol (1992) 2.06
Neural losses correlated with visual losses in clinical perimetry. Invest Ophthalmol Vis Sci (2004) 2.04
Long-term perimetric fluctuation in patients with different stages of glaucoma. Br J Ophthalmol (2010) 2.02
The onset and evolution of glaucomatous visual field defects. Ophthalmology (1982) 1.97
Regression analysis of visual field progression in low tension glaucoma. Br J Ophthalmol (1991) 1.96
Measuring visual field progression in the Early Manifest Glaucoma Trial. Acta Ophthalmol Scand (2003) 1.96
Pointwise univariate linear regression of perimetric sensitivity against follow-up time in glaucoma. Ophthalmology (1997) 1.80
Analysis of visual field progression in glaucoma. Br J Ophthalmol (1996) 1.78
Frequency of testing for detecting visual field progression. Br J Ophthalmol (2002) 1.77
Response variability in the visual field: comparison of optic neuritis, glaucoma, ocular hypertension, and normal eyes. Invest Ophthalmol Vis Sci (2000) 1.75
Analysis of progressive change in automated visual fields in glaucoma. Invest Ophthalmol Vis Sci (1996) 1.67
Confirmation of visual field abnormalities in the Ocular Hypertension Treatment Study. Ocular Hypertension Treatment Study Group. Arch Ophthalmol (2000) 1.62
The Advanced Glaucoma Intervention Study (AGIS): 1. Study design and methods and baseline characteristics of study patients. Control Clin Trials (1994) 1.57
Structure and function evaluation (SAFE): I. criteria for glaucomatous visual field loss using standard automated perimetry (SAP) and short wavelength automated perimetry (SWAP). Am J Ophthalmol (2002) 1.49
Comparing machine learning classifiers for diagnosing glaucoma from standard automated perimetry. Invest Ophthalmol Vis Sci (2002) 1.48
Estimating the rate of progressive visual field damage in those with open-angle glaucoma, from cross-sectional data. Invest Ophthalmol Vis Sci (2008) 1.47
Examination of different pointwise linear regression methods for determining visual field progression. Invest Ophthalmol Vis Sci (2002) 1.46
Comparison of different methods for detecting glaucomatous visual field progression. Invest Ophthalmol Vis Sci (2003) 1.46
The mode of progression of visual field defects in glaucoma. Am J Ophthalmol (1984) 1.45
Diffuse loss of sensitivity in early glaucoma. Invest Ophthalmol Vis Sci (1999) 1.44
Variability components of standard automated perimetry and frequency-doubling technology perimetry. Invest Ophthalmol Vis Sci (2001) 1.42
Errors in the diagnosis of visual field progression in normal-tension glaucoma. Ophthalmology (1994) 1.34
The use of visual field indices in detecting changes in the visual field in glaucoma. Invest Ophthalmol Vis Sci (1990) 1.32
Visual field progression in glaucoma: total versus pattern deviation analyses. Invest Ophthalmol Vis Sci (2005) 1.29
Variability in patients with glaucomatous visual field damage is reduced using size V stimuli. Invest Ophthalmol Vis Sci (1997) 1.29
Identifying glaucomatous vision loss with visual-function-specific perimetry in the diagnostic innovations in glaucoma study. Invest Ophthalmol Vis Sci (2006) 1.28
Prediction of glaucomatous visual field loss by extrapolation of linear trends. Arch Ophthalmol (2009) 1.25
Properties of the statpac visual field index. Invest Ophthalmol Vis Sci (2011) 1.23
Using machine learning classifiers to identify glaucomatous change earlier in standard visual fields. Invest Ophthalmol Vis Sci (2002) 1.23
The collaborative initial glaucoma treatment study: baseline visual field and test-retest variability. Invest Ophthalmol Vis Sci (2003) 1.20
Four-year incidence of visual impairment: Barbados Incidence Study of Eye Diseases. Ophthalmology (2004) 1.19
Unsupervised machine learning with independent component analysis to identify areas of progression in glaucomatous visual fields. Invest Ophthalmol Vis Sci (2005) 1.19
Longitudinal and cross-sectional analyses of visual field progression in participants of the Ocular Hypertension Treatment Study. Arch Ophthalmol (2010) 1.18
Estimating progression of visual field loss in glaucoma. Ophthalmology (1997) 1.16
Characteristics of frequency-of-seeing curves in normal subjects, patients with suspected glaucoma, and patients with glaucoma. Invest Ophthalmol Vis Sci (1993) 1.15
Perimetric probability maps to separate change caused by glaucoma from that caused by cataract. Acta Ophthalmol Scand (1997) 1.14
Long-term fluctuation of the visual field in glaucoma. Am J Ophthalmol (1992) 1.13
Prediction of visual field progression in glaucoma. Invest Ophthalmol Vis Sci (2004) 1.11
Patterns of glaucomatous visual field progression identified by three progression criteria. Am J Ophthalmol (2004) 1.11
A comparison of experienced clinical observers and statistical tests in detection of progressive visual field loss in glaucoma using automated perimetry. Arch Ophthalmol (1988) 1.10
Regression analysis of the central visual field in chronic glaucoma cases. A follow-up study using automatic perimetry. Acta Ophthalmol (Copenh) (1982) 1.10
Visual field index rate and event-based glaucoma progression analysis: comparison in a glaucoma population. Br J Ophthalmol (2009) 1.09
Spatial classification of glaucomatous visual field loss. Br J Ophthalmol (1996) 1.09
Comparison of methods to detect visual field progression in glaucoma . Ophthalmology (1997) 1.08
Interobserver agreement on visual field progression in glaucoma: a comparison of methods. Br J Ophthalmol (2003) 1.06
Infrequent confirmation of visual field progression. Ophthalmology (2002) 1.05
A comparison of visual field progression criteria of 3 major glaucoma trials in early manifest glaucoma trial patients. Ophthalmology (2008) 1.02
Performance of glaucoma progression analysis software in a glaucoma population. Graefes Arch Clin Exp Ophthalmol (2008) 1.02
Glaucoma surgery with or without adjunctive antiproliferatives in normal tension glaucoma: 2 Visual field progression. Br J Ophthalmol (2001) 1.00
Comparison of methods to predict visual field progression in glaucoma. Arch Ophthalmol (2007) 0.99
Diffuse visual field loss and glaucoma. Acta Ophthalmol (Copenh) (1994) 0.99
On the accuracy of measuring rates of visual field change in glaucoma. Br J Ophthalmol (2010) 0.98
Evaluating several sources of variability for standard and SWAP visual fields in glaucoma patients, suspects, and normals. Ophthalmology (2003) 0.96
Monitoring glaucomatous visual field progression: the effect of a novel spatial filter. Invest Ophthalmol Vis Sci (2007) 0.95
The Advanced Glaucoma Intervention Study (AGIS): 14. Distinguishing progression of glaucoma from visual field fluctuations. Ophthalmology (2004) 0.95
Differential light threshold in automated static perimetry. Factors influencing short-term fluctuation. Arch Ophthalmol (1984) 0.94
Unsupervised learning with independent component analysis can identify patterns of glaucomatous visual field defects. Trans Am Ophthalmol Soc (2005) 0.94
Detection of visual-field deterioration by Glaucoma Progression Analysis and Threshold Noiseless Trend programs. Br J Ophthalmol (2008) 0.94
Pointwise linear regression for evaluation of visual field outcomes and comparison with the advanced glaucoma intervention study methods. Arch Ophthalmol (2005) 0.90
Comparison of visual field progression in patients with normal pressure glaucoma between eyes with and without visual field loss that threatens fixation. Br J Ophthalmol (2000) 0.89
Pointwise linear regression analysis for detection of visual field progression with absolute versus corrected threshold sensitivities. Invest Ophthalmol Vis Sci (2006) 0.89
Criteria for progression of glaucoma in clinical management and in outcome studies. Am J Ophthalmol (2000) 0.89
Glaucoma monitoring in a clinical setting: glaucoma progression analysis vs nonparametric progression analysis in the Groningen Longitudinal Glaucoma Study. Arch Ophthalmol (2009) 0.88
Correlation of visual field progression between eyes in patients with open-angle glaucoma. Ophthalmology (2002) 0.88
Automatic detection of glaucomatous visual field progression with neural networks. Arch Ophthalmol (1997) 0.87
Bayes' theorem applied to perimetric progression detection in glaucoma: from specificity to positive predictive value. Graefes Arch Clin Exp Ophthalmol (2004) 0.87
Rate of visual field loss in progressive glaucoma. Arch Ophthalmol (2000) 0.87
The properties of perimetric thresholds in normal and glaucomatous eyes. Ger J Ophthalmol (1992) 0.87
Progression detection in glaucoma can be made more efficient by using a variable interval between successive visual field tests. Graefes Arch Clin Exp Ophthalmol (2007) 0.86
Glaucoma with early visual field loss affecting both hemifields and the risk of disease progression. Arch Ophthalmol (2009) 0.86
A comparison of the pattern- and total deviation-based Glaucoma Change Probability programs. Invest Ophthalmol Vis Sci (2000) 0.85
Static threshold examination of the peripheral nasal visual field in glaucoma. Arch Ophthalmol (1985) 0.85
Towards an optimal perimetric strategy for progression detection in glaucoma: from fixed-space to adaptive inter-test intervals. Graefes Arch Clin Exp Ophthalmol (2005) 0.84
Diffuse visual field loss in open-angle glaucoma. Ophthalmology (1991) 0.84
Appearance of the pattern deviation map as a function of change in area of localized field loss. Invest Ophthalmol Vis Sci (2004) 0.83
Repeatable diffuse visual field loss in open-angle glaucoma. Ophthalmology (1997) 0.82
Quantitative comparison of static perimetric strategies in early glaucoma: test-retest variability. J Glaucoma (2000) 0.82
Specification of progression in glaucomatous visual field loss, applying locally condensed stimulus arrangements. Graefes Arch Clin Exp Ophthalmol (2009) 0.81
A statistical trap in the evaluation of visual field decay. Acta Ophthalmol Suppl (1985) 0.81
Technique for determining glaucomatous visual field progression by using animation graphics. Am J Ophthalmol (1994) 0.81
Points of a normal visual field are not statistically independent. Ger J Ophthalmol (1995) 0.80
Effect of the number of threshold determinations on short-term fluctuation in automated perimetry. Ophthalmology (1991) 0.80
The structure-function relationship in eyes with glaucomatous visual field loss that crosses the horizontal meridian. Arch Ophthalmol (2002) 0.78
Optical coherence tomography to detect and manage retinal disease and glaucoma. Am J Ophthalmol (2004) 3.79
Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study. Ophthalmology (2004) 3.14
Macular ganglion cell/inner plexiform layer measurements by spectral domain optical coherence tomography for detection of early glaucoma and comparison to retinal nerve fiber layer measurements. Am J Ophthalmol (2013) 2.61
Comparison of optic nerve imaging methods to distinguish normal eyes from those with glaucoma. Invest Ophthalmol Vis Sci (2002) 2.22
Common variants at 9p21 and 8q22 are associated with increased susceptibility to optic nerve degeneration in glaucoma. PLoS Genet (2012) 2.00
Trabeculectomy with mitomycin C: outcomes and risk factors for failure in phakic open-angle glaucoma. Ophthalmology (2006) 1.87
Identifying early glaucoma with optical coherence tomography. Am J Ophthalmol (2004) 1.84
Graft failure after penetrating keratoplasty in eyes with Ahmed valves. Am J Ophthalmol (2010) 1.66
Evaluation of the hypertensive phase after insertion of the Ahmed Glaucoma Valve. Am J Ophthalmol (2003) 1.56
Relationship between visual field sensitivity and retinal nerve fiber layer thickness as measured by scanning laser polarimetry. Invest Ophthalmol Vis Sci (2004) 1.56
Intraocular pressure fluctuation: an independent risk factor for glaucoma? Arch Ophthalmol (2007) 1.54
Ahmed glaucoma valve and single-plate Molteno implants in treatment of refractory glaucoma: a comparative study. Am J Ophthalmol (2010) 1.52
Baerveldt-350 implant versus Ahmed valve for refractory glaucoma: a case-controlled comparison. J Glaucoma (2004) 1.52
Optic disc progression in glaucoma: comparison of confocal scanning laser tomography to optic disc photographs in a prospective study. Invest Ophthalmol Vis Sci (2008) 1.50
Long-term outcomes of primary trabeculectomy in diabetic patients with primary open angle glaucoma. Br J Ophthalmol (2013) 1.48
Optic disk appearance in advanced age-related macular degeneration. Am J Ophthalmol (2004) 1.43
Optic disk and nerve fiber layer imaging to detect glaucoma. Am J Ophthalmol (2007) 1.40
Glaucoma care in a patient with previous anterior ciliary sclerotomy and scleral expansion procedure. Arch Ophthalmol (2003) 1.40
Long-term outcomes of Ahmed glaucoma valve implantation in refractory glaucomas. Am J Ophthalmol (2007) 1.31
Measurement of optic disc size and rim area with spectral-domain OCT and scanning laser ophthalmoscopy. Invest Ophthalmol Vis Sci (2012) 1.29
Retinal ganglion cell protection with geranylgeranylacetone, a heat shock protein inducer, in a rat glaucoma model. Invest Ophthalmol Vis Sci (2003) 1.29
Pars plana anterior vitrectomy, hyaloido-zonulectomy, and iridectomy for aqueous humor misdirection. Am J Ophthalmol (2010) 1.26
Comparison of retinal nerve fiber layer thickness and optic disk algorithms with optical coherence tomography to detect glaucoma. Am J Ophthalmol (2006) 1.20
Long-term outcomes of repeat vs initial trabeculectomy in open-angle glaucoma. Am J Ophthalmol (2009) 1.18
RNA binding protein with multiple splicing: a new marker for retinal ganglion cells. Invest Ophthalmol Vis Sci (2009) 1.17
Trabeculectomy with mitomycin C in pseudophakic patients with open-angle glaucoma: outcomes and risk factors for failure. Am J Ophthalmol (2006) 1.15
Structure-function relationships between spectral-domain OCT and standard achromatic perimetry. Invest Ophthalmol Vis Sci (2012) 1.13
Calpain and N-methyl-d-aspartate (NMDA)-induced excitotoxicity in rat retinas. Brain Res (2005) 1.12
Feasibility and efficacy of a mass switch from latanoprost to bimatoprost in glaucoma patients in a prepaid Health Maintenance Organization. Ophthalmology (2005) 1.11
Variable corneal compensation improves discrimination between normal and glaucomatous eyes with the scanning laser polarimeter. Ophthalmology (2004) 1.11
Prediction of visual field progression in glaucoma. Invest Ophthalmol Vis Sci (2004) 1.11
Dynamic tube movement of Ahmed glaucoma valve. J Glaucoma (2009) 1.10
Corneal endothelial cell injury induced by mitomycin-C in photorefractive keratectomy: nonrandomized controlled trial. J Cataract Refract Surg (2008) 1.09
Surgical management of pediatric glaucoma. Dev Ophthalmol (2012) 1.08
Comparison of safety and efficacy between silicone and polypropylene Ahmed glaucoma valves in refractory glaucoma. Ophthalmology (2005) 1.08
Detection of early glaucoma with optical coherence tomography (StratusOCT). J Glaucoma (2008) 1.07
Modulation of alpha and beta crystallin expression in rat retinas with ocular hypertension-induced ganglion cell degeneration. Brain Res (2007) 1.06
Severe loss of central vision in patients with advanced glaucoma undergoing trabeculectomy. Arch Ophthalmol (2007) 1.06
Subconjunctival bevacizumab versus mitomycin C adjunctive to trabeculectomy. Am J Ophthalmol (2011) 1.04
Visual field changes after cataract extraction: the AGIS experience. Am J Ophthalmol (2004) 1.04
Quantitative analysis of retinal ganglion cell survival with Rbpms immunolabeling in animal models of optic neuropathies. Invest Ophthalmol Vis Sci (2011) 1.03
Frequency-doubling perimetry: comparison with standard automated perimetry to detect glaucoma. Am J Ophthalmol (2006) 1.01
Activation of autophagy in retinal ganglion cells. J Neurosci Res (2008) 1.00
Comparison of methods to predict visual field progression in glaucoma. Arch Ophthalmol (2007) 0.99
The importance of rates in glaucoma. Am J Ophthalmol (2008) 0.99
Gene expression changes in the retina following optic nerve transection. Mol Vis (2006) 0.99
The role of alphaA- and alphaB-crystallins in the survival of retinal ganglion cells after optic nerve axotomy. Invest Ophthalmol Vis Sci (2009) 0.98
The association between retinal vessel diameter and retinal nerve fiber layer thickness in asymmetric normal tension glaucoma patients. Invest Ophthalmol Vis Sci (2012) 0.98
Correction for the erroneous compensation of anterior segment birefringence with the scanning laser polarimeter for glaucoma diagnosis. Invest Ophthalmol Vis Sci (2002) 0.97
Evaluating several sources of variability for standard and SWAP visual fields in glaucoma patients, suspects, and normals. Ophthalmology (2003) 0.96
Influence of visual field testing frequency on detection of glaucoma progression with trend analyses. Arch Ophthalmol (2011) 0.96
Development of a novel reference plane for the Heidelberg retina tomograph with optical coherence tomography measurements. J Glaucoma (2002) 0.95
The dark phase intraocular pressure elevation and retinal ganglion cell degeneration in a rat model of experimental glaucoma. Exp Eye Res (2013) 0.94
Outcomes of Ahmed glaucoma valve implantation in children with primary congenital glaucoma. Arch Ophthalmol (2009) 0.94
Protective effect of thioredoxins 1 and 2 in retinal ganglion cells after optic nerve transection and oxidative stress. Invest Ophthalmol Vis Sci (2008) 0.94
Effect of intravitreal bevacizumab on retrobulbar blood flow in injected and uninjected fellow eyes of patients with neovascular age-related macular degeneration. Retina (2012) 0.93
Sequential office pressure measurements in the management of glaucoma. J Glaucoma (2005) 0.93
Expression of hermes gene is restricted to the ganglion cells in the retina. Neurosci Lett (2006) 0.90
Expression of phosphorylated c-Jun N-terminal protein kinase (JNK) in experimental glaucoma in rats. Exp Eye Res (2005) 0.90
Pointwise linear regression for evaluation of visual field outcomes and comparison with the advanced glaucoma intervention study methods. Arch Ophthalmol (2005) 0.90
The neuronal EGF-related gene Nell2 interacts with Macf1 and supports survival of retinal ganglion cells after optic nerve injury. PLoS One (2012) 0.89
Pointwise linear regression analysis for detection of visual field progression with absolute versus corrected threshold sensitivities. Invest Ophthalmol Vis Sci (2006) 0.89
Changes in intraocular pressure after pharmacologic pupil dilation. BMC Ophthalmol (2012) 0.89
Retinal nerve fiber thickness is reduced in sleep apnea syndrome. Sleep Med (2012) 0.88
Hyperthermic pre-conditioning protects retinal neurons from N-methyl-D-aspartate (NMDA)-induced apoptosis in rat. Brain Res (2003) 0.88
Asymmetric phenotype of Axenfeld-Rieger anomaly and aniridia associated with a novel PITX2 mutation. Mol Vis (2011) 0.88
Co-expression of heat shock transcription factors 1 and 2 in rat retinal ganglion cells. Neurosci Lett (2006) 0.87
Measurement of the optic disc vertical tilt angle with spectral-domain optical coherence tomography and influencing factors. Am J Ophthalmol (2013) 0.87
A comparison of corneal endothelial cell changes after 1-site and 2-site phacotrabeculectomy. Cornea (2008) 0.87
Baseline prognostic factors predict rapid visual field deterioration in glaucoma. Invest Ophthalmol Vis Sci (2014) 0.86
Hemorrhagic complications from glaucoma surgery in patients on anticoagulation therapy or antiplatelet therapy. Am J Ophthalmol (2008) 0.85
Frequency doubling perimetry and short-wavelength automated perimetry to detect early glaucoma. Ophthalmology (2007) 0.84
Visual outcome and contrast sensitivity after photorefractive keratectomy in low to moderate myopia: wavefront-optimized versus conventional methods. J Cataract Refract Surg (2011) 0.84
Validation of point-wise exponential regression to measure the decay rates of glaucomatous visual fields. Invest Ophthalmol Vis Sci (2012) 0.84
Control of intraocular pressure and fluctuation with fixed-combination brimonidine-timolol versus brimonidine or timolol monotherapy. Am J Ophthalmol (2011) 0.83
The logic behind target intraocular pressure. Am J Ophthalmol (2009) 0.83
Outcomes of small-incision cataract surgery in eyes with preexisting Ahmed Glaucoma Valves. Am J Ophthalmol (2005) 0.83
The tube versus trabeculectomy study: why its findings may not change clinical practice? Am J Ophthalmol (2011) 0.82
The treatment of normal-tension glaucoma. Prog Brain Res (2008) 0.82
Erythropoietin levels in aqueous humor of patients with glaucoma. Mol Vis (2012) 0.82
Conjunctival limbal autograft and allograft transplantation using fibrin glue. Ophthalmic Surg Lasers Imaging (2012) 0.82
Outcomes of laser suture lysis after initial trabeculectomy with adjunctive mitomycin C. J Glaucoma (2006) 0.81
Diagnosing glaucoma progression: current practice and promising technologies. Curr Opin Ophthalmol (2006) 0.81
Author response: On alternative methods for measuring visual field decay: Tobit linear regression. Invest Ophthalmol Vis Sci (2012) 0.80
Pointwise rates of visual field progression cluster according to retinal nerve fiber layer bundles. Invest Ophthalmol Vis Sci (2012) 0.80
Comparison of clinical characteristics between Korean and Western normal-tension glaucoma patients. Am J Ophthalmol (2013) 0.80
Early Aqueous Suppressant Therapy on Hypertensive Phase Following Glaucoma Drainage Device Procedure: A Randomized Prospective Trial. J Glaucoma (2016) 0.80
Characterization of retinal nerve fiber layer in nonglaucomatous eyes with tilted discs. Arch Ophthalmol (2010) 0.79
Expression of heat shock transcription factors and heat shock protein 72 in rat retina after intravitreal injection of low dose N-methyl-D-aspartate. Neurosci Lett (2007) 0.79
Oscillatory photodynamic therapy for choroidal neovascularization and central serous retinopathy; a pilot study. J Ophthalmic Vis Res (2011) 0.79
Crystallins in retinal ganglion cell survival and regeneration. Mol Neurobiol (2013) 0.78
Clinical cystoid macular edema after cataract surgery in glaucoma patients. J Glaucoma (2010) 0.78
The Relationship of the Clinical Disc Margin and Bruch's Membrane Opening in Normal and Glaucoma Subjects. Invest Ophthalmol Vis Sci (2016) 0.77
Dynamic contour tonometry in primary open angle glaucoma and pseudoexfoliation glaucoma: factors associated with intraocular pressure and ocular pulse amplitude. Middle East Afr J Ophthalmol (2013) 0.77
Longitudinal structure-function relationships with scanning laser ophthalmoscopy and standard achromatic perimetry. Arch Ophthalmol (2012) 0.77